INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-2223536069 protein]( "Enable Low Volume Delivery Of Proteins In Aqueous Solutions")
Enable Low Volume Delivery Of Proteins In Aqueous SolutionsAchieve ultra-low volume dispensing of proteins and aqueous solutions without surfactants with consistent precision, minimal contamination, and broad compatibility to streamline your lab workflow.
-
![GettyImages-2163606903-gloves-pipet-cell-culture-assay]( "Simplify Cell Line Development")
Simplify Cell Line DevelopmentExplore a streamlined method for isolating viable single cells using microfluidic dispensing and whole-well imaging that is designed to improve clonality, cell health, and reproducibility.
-
![CAR-T Strategy In 2026: Scaling Autologous, Advancing Allogeneic]( "CAR-T Strategy In 2026: Scaling Autologous, Advancing Allogeneic")
CAR-T Strategy In 2026: Scaling Autologous, Advancing AllogeneicAs CAR-T advances, shifting clinical progress and market dynamics are reshaping development strategies. Explore how evolving therapies and operational demands are redefining the next wave of innovation.
-
![Use Of Spray Drying In Pharmaceutical Product Development]( "Use Of Spray Drying In Pharmaceutical Product Development")
Use Of Spray Drying In Pharmaceutical Product DevelopmentThrough this detailed exploration, participants will gain valuable knowledge on how to leverage spray drying to optimize drug development and delivery.
-
Maintain Control Of Pharmaceutical Water Systems4/10/2026
Early TOC excursions often reveal hidden risks in water systems. Capturing samples at the moment of deviation helps teams confirm root causes faster, reduce uncertainty, and maintain control.
-
Where Speed Meets Complexity In Bioprocess Development6/18/2026
Bioprocessing faces mounting pressure to compress timelines, especially for mAbs, while complex modalities like bispecifics and gene therapies introduce technical challenges. Process intensification, scale-up translation, and comparability risks remain critical hurdles.
-
A CDMO Is The Nexus Between Green Chemistry And Commercialization2/24/2026
Modern R&D transforms sustainability from an optional add-on into a strategic optimization tool, enhancing cost-efficiency, speed to market, and process intensification for drug developers.
-
Quantification Of Exenatide Using Xevo TQD7/29/2025
Discover a highly sensitive and reliable LC-MS/MS method for quantifying exenatide in plasma that is powered by advanced sample prep and optimized column chemistries.
-
Data-Driven Strategies To De-Risk OSD Development6/17/2026
Watch as Quentin Horgan, Director of Drugs Intelligence at GlobalData discusses how early-stage insights can improve development outcomes and reduce downstream risk.
DRUG DEVELOPMENT SOLUTIONS
-
![mPredict™ Co-Crystal Prediction Service]( "Co-Crystal Prediction Service")
AI-driven co-crystal prediction accelerates solubility optimization by identifying ideal co-formers in days without needing the drug substance. Learn how to save time, reduce costs, and boost formulation success.
-
![Scientists laboratory thinking GettyImages-1206395543]( "Is NSA Sabotaging Your Lab's Productivity")
Waters MaxPeak Premier Columns and Solutions dramatically reduce NSA with MaxPeak High Performance Surfaces, innovative technologies designed to reduce analyte loss due to analyte/surface interactions.
-
![GettyImages-155374807-molecule-molecular]( "Small Molecules Discovery")
Whether you require a particular expertise or a complete, experienced integrated small molecule discovery team, Curia can provide a high-performance solution to help turn your vision into reality.
-
![GettyImages-171223483-cell-culture-microscope-assay]( "Assay Development And Screening")
We deliver custom assay development, screening, potency, and selectivity testing services for the pharmaceutical, biopharmaceutical, and agrochemical industries.
-
![iStock-1214764688-scientist-lab-analyze-research]( "Analytical And Testing Services")
As part of Stevanato Group’s commitment to R&D, our analytical testing facilities focus on investigating physico-chemical properties of primary packaging materials and components and studying the interactions between container closure system and drugs. Stevanato Group relies on a multi-disciplinary team of highly skilled professionals, including, scientists, engineers, pharmaceutical chemists and biotechnologists. Their knowledge and experience covers a range of specialized areas including container closure systems and drug-delivery devices.
